Reduction of blood loss and transfusion requirements after coronary artery bypass grafting: Similar efficacy of tranexamic acid and aprotinin in aspirin-treated patients

Journal of Cardiac Surgery

Volumn 14, Issue 2, 1999, Pages 92-97

  Bernet, Franziska ^a   Carrel, Thierry ^b   Marbet, German ^b   Skarvan, Karl ^b   Stulz, Peter ^b  

^a University Hospital   (Switzerland)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

APROTININ; TRANEXAMIC ACID;

ADULT; ARTICLE; BLOOD TRANSFUSION; CARDIOVASCULAR DISEASE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; CORONARY ARTERY SURGERY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; POSTOPERATIVE CARE; POSTOPERATIVE HEMORRHAGE; RANDOMIZED CONTROLLED TRIAL;

EID: 0033491228     PISSN: 08860440     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1540-8191.1999.tb00956.x     Document Type: Article

References (34)

1. Harker LA: Bleeding after cardiopulmonary bypass. N Engl J Med 1986;314:1446-1447.
2. Karski JM, Teasdale SJ, Norman P, et al: Prevention of bleeding after cardiopulmonary bypass with high-dose tranexamic acid. J Thorac Cardiovasc Surg 1995;110:835-842.
3. Salzmann EW, Weinstein MJ, Weintraub RM, et al: Treatment with desmopressin acetate to reduce blood loss after cardiac surgery: A double-blind randomized trial. N Engl J Med 1986;314: 1402-1406.
4. Cohen ND, Munoz A, Reitz PD, et al: Transmission of retroviruses by transfusion screened blood in patients undergoing cardiac surgery. N Engl J Med 1989;320:1172-1176.
5. Khuri SF, Wolfe JA, Josa M, et al: Hematologic changes during and after cardiopulmonary bypass and their relationship to the bleeding time and nonsurgical blood loss. J Thorac Cardiovasc Surg 1992;104:94-107.
6. Holloway DS, Summaria L, Sandesara J, et al: Decreased platelet number and function and increased fibrinolysis contribute to postoperative bleeding in cardiopulmonary bypass patients. Thromb Haemost 1988;59:62-67.
7. Harker LA, Malpass TW, Branson HE, et al: Mechanism of abnormal bleeding in patients undergoing cardiopulmonary bypass: Acquired transient platelet dysfunction associated with selective α-granule release. Blood 1980;56:824-834.
8. Woodman RC, Harker LA: Bleeding complications associated with cardiopulmonary bypass. Blood 1990;76:1680-1697.
9. Kestin AS, Valeri CP, Khuri SF, et al: The platelet function defect of cardio-pulmonary bypass. Blood 1993;82:107-117.
10. Chesebro JH, Clements IP, Fuster V, et al: Platelet-inhibitor-drug trial in coronary artery bypass operations. Benefit of perioperative dipyramidole and aspirin therapy on early postoperative vein graft patency. N Engl J Med 1982;307(Suppl 2):73-78.
11. Goldman S, Copeland J, Moritz T, et al: Improvement in early saphenous vein graft patency after coronary artery bypass surgery with antiplatelet therapy. Circulation 1988;77:1324-1332.
12. Goldman S, Copeland J, Moritz T, et al: Saphenous vein graft patency 1 year after coronary artery bypass surgery and effects of antiplatelet therapy. Results of a VACS. Circulation 1989;80:1190-1197.
13. Ferraris VA, Ferraris SP, Lough FC, et al: Preoperative aspirin ingestion increases operative blood loss after coronary artery bypass grafting. Ann Thorac Surg 1988;45:71-74.
14. Sethi GK, Copeland JG, Goldman S, et al: Implications of preoperative administration of aspirin in patients undergoing coronary artery bypass grafting. J Am Coll Cardiol 1990;15:15-20.
15. Taggart DP, Siddiqui A, Wheatley DJ: Low-dose preoperative aspirin therapy, postoperative blood loss, and transfusion requirements. Ann Thorac Surg 1990;50:425-428.
16. Kallis P, Tooze JA, Talbot S, et al: Preoperative aspirin decreases platelet aggregation and increases postoperative blood loss. A prospective, randomized placebo controlled, double-blind trial in 100 patients with chronic stable angina. Eur J Cardiothorac Surg 1994;8:404-409.
17. Ferraris VA, Ferraris SP: Aspirin and postoperative blood loss. Up date. Ann Thorac Surg 1995;59: 1036-1037.
18. Guenther CR: Pro: Tranexamic acid is better than aprotinin in decreasing bleeding after cardiac surgery, J Cardiothorac Vasc Anesth 1994;8:471-473.
19. Soslau G, Horrow J, Brodsky I: Effect of tranexamic acid on platelet ADP during extracorporal circulation. Am J Hematol 1991;38:113-119.
20. Wildevuur CRH, Eijsman L, Roozendaal KJ, et al: Platelet preservation during cardiopulmonary bypass with aprotinin. Eur J Cardiothorac Surg 1989; 3:533-538.
21. Van Oeveren W, Harder MP, Roozendaal KJ, et al: Aprotinin protects platelet against the initial effect of cardiopulmonary bypass. J Thorac Cardiovasc Surg 1990;99:788-797.
22. Bidstrup BP, Royston D, Sapsford RN, et al: Reduction in blood loss and blood use after cardiopulmonary bypass with high-dose aprotinin (Trasylol). J Thorac Cardiovasc Surg 1989;97:364-372.
23. Blauhut B, Gross C, Necek S, et al: Effects of high-dose aprotinin on blood loss, platelet function, fibrinolysis, complement, and renal function after cardiopulmonary bypass. J Thorac Cardiovasc Surg 1991;101:958-967.
24. Royston D: High-dose aprotinin therapy: A review of the first five years' experience. J Cardiothorac Vasc Surg 1992;6:76-100.
25. Cosgrove DM III, Heric B, Lytle BW, et al: Aprotinin therapy for reoperative myocardial revascularization: A placebo-controlled study. Ann Thorac Surg 1992;54:1031-1038.
26. Bidstrup BP, Underwood SR, Sapsford RN, et al: Effect of aprotinin (Trasylol) on aorta-coronary bypass graft patency. J Thorac Cardiovasc Surg 1993;105:147-153.
27. Westaby S: Aprotinin in perspective. Ann Thorac Surg 1993;55:1033-1041.
28. Lemmer JH, Standford W, Bonney SL, et al: Aprotinin for coronary bypass operations: Efficacy, safety, and influence on early saphenous vein graft patency. J Thorac Cardiovasc Surg 1994;107:543-553.
29. Murkin JM, Lux J, Shannon NA, et al: Aprotinin significantly decreases bleeding and transfusion requirements in patients receiving aspirin and undergoing cardiac operations. J Thorac Cardiovasc Surg 1994;107:554-561.
30. Lemmer JH, Standford W, Bonney SL, et al: Aprotinin for coronary artery bypass grafting: Effect on postoperative renal function. Ann Thorac Surg 1995;59:132-136.
31. Horrow JC, Hlavacek J, Strong MID, et al: Prophylactic tranexamic acid decreases bleeding after cardiac operations. J Thorac Cardiovasc 1990;99:70-74.
32. Rousou JA, Engelman RM, Flack JE III, et al: Tranexamic acid significantly reduces blood loss associated with coronary revascularisation. Ann Thorac Surg 1995;59:671-675.
33. Katsaros D, Petricevic M, Snow NJ, et al: Tranexamic acid reduces postbypass blood use: A double-blinded, prospective, randomized study of 210 patients. Ann Thorac Surg 1996;61:1131-1135.
34. Blauhut B, Harringer W, Bettelheim P, et al: Comparison of the effects of aprotinin and tranexamic acid on blood loss and related variables after cardiopulmonary bypass. J Thorac Cardiovasc Surg 1994;108:1083-1091.